Results 21 to 30 of about 386,203 (191)

Combination formoterol and inhaled steroid versus beta(2)-agonist as relief medication for chronic asthma in adults and children (Review) [PDF]

open access: yes, 2009
Background Formoterol has a fast onset of action and can therefore be used to relieve symptoms of asthma. A combination inhaler can deliver formoterol with different doses of inhaled corticosteroid; when used as a reliever both drugs will be delivered ...
Adams   +46 more
core   +1 more source

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis [PDF]

open access: yes, 2015
The aim of this study was to examine the relationship between pulmonary exacerbations and physical activity (PA) in adults with cystic fibrosis (CF)
Banya, Winston   +7 more
core   +2 more sources

Exacerbations [PDF]

open access: yesBioSocieties, 2019
[No Abstract]
openaire   +2 more sources

Continuous cough monitoring using ambient sound recording during convalescence from a COPD exacerbation [PDF]

open access: yes, 2017
Purpose Cough is common in chronic obstructive pulmonary disease (COPD) and is associated with frequent exacerbations and increased mortality. Cough increases during acute exacerbations (AE-COPD), representing a possible metric of clinical deterioration.
Crooks, Michael G.   +7 more
core   +1 more source

Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids : A Historical Cohort Study [PDF]

open access: yes, 2017
This work was supported by the Respiratory Effectiveness Group. Acknowledgments We thank the Respiratory Effectiveness Group for funding this work, Annie Burden for assistance with statistics, and Simon Van Rysewyk and Lisa Law for assistance with ...
Murray, Claire S.   +4 more
core   +2 more sources

Acute Exacerbation of COPD

open access: yesJournal of Education and Teaching in Emergency Medicine, 2023
This case is targeted to emergency medicine residents of all levels.Shortness of breath (SOB) is one of the top ten most common chief complaints seen in the Emergency Department, accounting for close to 10% of presenting complaints.1 An acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a frequent culprit, accounting for roughly 15.
Pappas, Dominic, Vempati, Amrita
openaire   +4 more sources

Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. [PDF]

open access: yes, 2015
© 2015, The Author(s).Introduction: There is a lack of agreed and established guidelines for the treatment of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF).
Bennett, BM   +8 more
core   +2 more sources

Serum Uric Acid in Chronic Obstructive Pulmonary Disease: A Hospital Based Case Control Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Airway inflammation and imbalance between oxidant/ anti-oxidant mechanisms are postulated to play a major role in the pathogenesis and exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
Rajlaxmi Sarangi   +5 more
doaj   +1 more source

Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review). [PDF]

open access: yes, 2011
Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler.
Agarwal   +105 more
core   +2 more sources

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD):a prospective observational study [PDF]

open access: yes, 2018
COPD exacerbations are commonly quantified as rate per year. However, the total amount of time a patient suffers from exacerbations may be stronger related to his or her disease burden than just counting exacerbation episodes.
Akkermans, R P   +7 more
core   +12 more sources

Home - About - Disclaimer - Privacy